Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tazeen Ahmad is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/25/2024 | MRUS | Buy Now | Merus | $59.17 | 28.44% | $76 → $76 | Maintains | Buy | Get Alert |
| 06/24/2024 | ARGX | Buy Now | argenx | $430.04 | 41.15% | $535 → $607 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2024 | PTCT | Buy Now | PTC Therapeutics | $30.00 | 6.67% | $25 → $32 | Maintains | Underperform | Get Alert |
| 06/21/2024 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 34.81% | $166 → $213 | Maintains | Buy | Get Alert |
| 06/05/2024 | MRUS | Buy Now | Merus | $59.17 | 28.44% | $80 → $76 | Maintains | Buy | Get Alert |
| 05/31/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.10 | 84.91% | $83 → $76 | Maintains | Buy | Get Alert |
| 05/29/2024 | MRUS | Buy Now | Merus | $59.17 | 35.2% | $61 → $80 | Maintains | Buy | Get Alert |
| 05/24/2024 | MRUS | Buy Now | Merus | $59.17 | 3.09% | $52 → $61 | Maintains | Buy | Get Alert |
| 05/10/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $16.22 | 35.64% | $26 → $22 | Maintains | Neutral | Get Alert |
| 05/10/2024 | FOLD | Buy Now | Amicus Therapeutics | $9.92 | 31.05% | $14 → $13 | Maintains | Buy | Get Alert |
| 05/08/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $41.06 | 2.29% | $49 → $42 | Downgrade | Buy → Neutral | Get Alert |
| 05/08/2024 | STRO | Buy Now | Sutro Biopharma | $3.00 | 300% | → $12 | Initiates | → Buy | Get Alert |
| 04/17/2024 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 29.03% | $24 → $14 | Downgrade | Neutral → Underperform | Get Alert |
| 04/09/2024 | INZY | Buy Now | Inozyme Pharma | $4.46 | 213.9% | $16 → $14 | Maintains | Buy | Get Alert |
| 03/28/2024 | ANNX | Buy Now | Annexon | $4.84 | 106.61% | $7 → $10 | Maintains | Buy | Get Alert |
| 03/28/2024 | FATE | Buy Now | Fate Therapeutics | $3.28 | 82.93% | $2 → $6 | Maintains | Underperform | Get Alert |
| 03/13/2024 | INCY | Buy Now | Incyte | $60.62 | 10.52% | $69 → $67 | Maintains | Neutral | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $16.22 | 84.96% | $33 → $30 | Maintains | Neutral | Get Alert |
| 02/09/2024 | OCUL | Buy Now | Ocular Therapeutix | $6.84 | 119.3% | → $15 | Initiates | → Buy | Get Alert |
| 01/30/2024 | PRTA | Buy Now | Prothena Corp | $20.64 | 84.11% | $68 → $38 | Downgrade | Buy → Neutral | Get Alert |
| 01/05/2024 | CYT | Buy Now | Cyteir Therapeutics | — | — | → $3 | Downgrade | Neutral → Underperform | Get Alert |
| 12/21/2023 | ANNX | Buy Now | Annexon | $4.84 | 23.97% | $4 → $6 | Upgrade | Neutral → Buy | Get Alert |
| 12/14/2023 | ACHL | Buy Now | Achilles Therapeutics | $0.84 | -40.41% | $7 → $0.5 | Downgrade | Buy → Underperform | Get Alert |
| 12/07/2023 | PHVS | Buy Now | Pharvaris | $18.01 | -38.92% | $8 → $11 | Maintains | Underperform | Get Alert |
| 12/05/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $38.90 | 118.51% | $52 → $85 | Upgrade | Neutral → Buy | Get Alert |
| 09/19/2023 | PTCT | Buy Now | PTC Therapeutics | $30.00 | -23.33% | $43 → $23 | Maintains | Underperform | Get Alert |
| 09/08/2023 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 121.2% | $25 → $24 | Maintains | Neutral | Get Alert |
| 08/03/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.89 | -24.19% | $36 → $31 | Downgrade | Buy → Neutral | Get Alert |
| 08/02/2023 | RYTM | Buy Now | Rhythm Pharmaceuticals | $41.06 | -34.24% | $22 → $27 | Upgrade | Neutral → Buy | Get Alert |
| 07/13/2023 | BCRX | Buy Now | BioCryst Pharma | $6.15 | 62.6% | → $10 | Upgrade | Neutral → Buy | Get Alert |
| 06/08/2023 | FDMT | Buy Now | 4D Molecular Therapeutics | $20.99 | 57.22% | $28 → $33 | Maintains | Buy | Get Alert |
| 05/26/2023 | ANNX | Buy Now | Annexon | $4.84 | -38.02% | $8 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 05/24/2023 | PTCT | Buy Now | PTC Therapeutics | $30.00 | 40% | → $42 | Maintains | Underperform | Get Alert |
| 05/23/2023 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 462.21% | $56 → $61 | Maintains | Buy | Get Alert |
| 05/22/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $16.22 | 60.3% | $23 → $26 | Maintains | Neutral | Get Alert |
| 05/18/2023 | PTCT | Buy Now | PTC Therapeutics | $30.00 | 43.33% | $36 → $43 | Maintains | Underperform | Get Alert |
| 05/15/2023 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 11.39% | $164 → $176 | Maintains | Buy | Get Alert |
| 05/10/2023 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 3.8% | $164 → $164 | Maintains | Buy | Get Alert |
| 05/04/2023 | INCY | Buy Now | Incyte | $60.62 | 38.57% | $93 → $84 | Downgrade | Buy → Neutral | Get Alert |
| 05/03/2023 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 416.13% | $55 → $56 | Maintains | Buy | Get Alert |
| 04/24/2023 | ADCT | Buy Now | ADC Therapeutics | $3.16 | -36.71% | $7 → $2 | Downgrade | Neutral → Underperform | Get Alert |
| 04/14/2023 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 3.8% | $164 → $164 | Maintains | Buy | Get Alert |
| 04/04/2023 | ASND | Buy Now | Ascendis Pharma | $136.38 | -32.54% | $132 → $92 | Maintains | Buy | Get Alert |
| 03/28/2023 | BNTX | Buy Now | BioNTech | $81.89 | 136.9% | $239 → $194 | Maintains | Buy | Get Alert |
| 03/28/2023 | FOLD | Buy Now | Amicus Therapeutics | $9.92 | 71.37% | $16 → $17 | Maintains | Buy | Get Alert |
| 03/20/2023 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 3.8% | $164 → $164 | Maintains | Buy | Get Alert |
| 03/17/2023 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 3.8% | → $164 | Maintains | Buy | Get Alert |
| 03/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $16.22 | 41.8% | → $23 | Maintains | Neutral | Get Alert |
| 02/28/2023 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 1.27% | → $160 | Maintains | Buy | Get Alert |
| 02/22/2023 | PTCT | Buy Now | PTC Therapeutics | $30.00 | 20% | → $36 | Maintains | Underperform | Get Alert |
| 02/16/2023 | GRTX | Buy Now | Galera Therapeutics | $0.14 | 5016.96% | $2 → $7 | Upgrade | Underperform → Buy | Get Alert |
| 02/06/2023 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 406.91% | → $55 | Maintains | Buy | Get Alert |
| 01/30/2023 | CYT | Buy Now | Cyteir Therapeutics | — | — | $4 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $3.28 | 21.95% | $72 → $4 | Downgrade | Buy → Underperform | Get Alert |
| 12/15/2022 | BNTX | Buy Now | BioNTech | $81.89 | 191.85% | → $239 | Upgrade | Neutral → Buy | Get Alert |
| 12/01/2022 | SQZ | Buy Now | SQZ Biotechnologies | — | — | $90 → $20 | Downgrade | Buy → Underperform | Get Alert |
| 11/29/2022 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -12.66% | $129 → $138 | Maintains | Buy | Get Alert |
| 11/21/2022 | PRLD | Buy Now | Prelude Therapeutics | $3.81 | 57.48% | → $6 | Downgrade | Neutral → Underperform | Get Alert |
| 11/17/2022 | SRZN | Buy Now | Surrozen | $10.95 | -90.87% | $75 → $15 | Downgrade | Neutral → Underperform | Get Alert |
| 11/09/2022 | ADCT | Buy Now | ADC Therapeutics | $3.16 | 121.52% | $14 → $7 | Downgrade | Buy → Neutral | Get Alert |
| 11/03/2022 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -18.35% | $130 → $129 | Maintains | Buy | Get Alert |
| 10/20/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.89 | -4.62% | → $39 | Initiates | → Buy | Get Alert |
| 09/28/2022 | PRTA | Buy Now | Prothena Corp | $20.64 | — | → $65 | Upgrade | Neutral → Buy | Get Alert |
| 08/22/2022 | PHVS | Buy Now | Pharvaris | $18.01 | -27.82% | $26 → $13 | Downgrade | Neutral → Underperform | Get Alert |
| 08/18/2022 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -21.52% | $104 → $124 | Maintains | Buy | Get Alert |
| 08/05/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $41.06 | -51.29% | $8 → $20 | Upgrade | Underperform → Neutral | Get Alert |
| 06/07/2022 | PRAX | Buy Now | Praxis Precision Medicine | $42.20 | -90.52% | $390 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 05/31/2022 | PEPG | Buy Now | PepGen | $15.96 | 0.25% | → $16 | Initiates | → Buy | Get Alert |
| 05/27/2022 | SRZN | Buy Now | Surrozen | $10.95 | -54.34% | → $75 | Downgrade | Buy → Neutral | Get Alert |
| 05/27/2022 | MTEM | Buy Now | Molecular Templates | $1.06 | 41.51% | → $22.5 | Downgrade | Buy → Underperform | Get Alert |
| 05/27/2022 | GRTX | Buy Now | Galera Therapeutics | $0.14 | 1361.99% | → $2 | Downgrade | Neutral → Underperform | Get Alert |
| 04/19/2022 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -32.28% | $105 → $107 | Maintains | Buy | Get Alert |
| 04/19/2022 | PTCT | Buy Now | PTC Therapeutics | $30.00 | 10% | $34 → $33 | Maintains | Underperform | Get Alert |
| 04/11/2022 | BCRX | Buy Now | BioCryst Pharma | $6.15 | 127.65% | → $14 | Downgrade | Buy → Neutral | Get Alert |
| 03/15/2022 | ASND | Buy Now | Ascendis Pharma | $136.38 | 18.05% | $148 → $161 | Upgrade | Neutral → Buy | Get Alert |
| 03/15/2022 | PRLD | Buy Now | Prelude Therapeutics | $3.81 | 162.47% | $50 → $10 | Downgrade | Buy → Neutral | Get Alert |
| 03/03/2022 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -33.54% | $105 → $105 | Maintains | Buy | Get Alert |
| 03/01/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $16.22 | 91.12% | $32 → $31 | Maintains | Neutral | Get Alert |
| 02/25/2022 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 351.61% | $50 → $49 | Maintains | Buy | Get Alert |
| 01/26/2022 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -33.54% | $122 → $105 | Maintains | Buy | Get Alert |
| 01/13/2022 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -22.78% | $122 → $122 | Maintains | Buy | Get Alert |
| 01/12/2022 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 453% | → $60 | Maintains | Buy | Get Alert |
| 12/21/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $16.22 | 97.29% | $28 → $32 | Maintains | Neutral | Get Alert |
| 10/11/2021 | SRZN | Buy Now | Surrozen | $10.95 | 0.46% | → $165 | Initiates | → Buy | Get Alert |
| 08/26/2021 | PRAX | Buy Now | Praxis Precision Medicine | $42.20 | -33.65% | → $420 | Initiates | → Buy | Get Alert |
| 08/05/2021 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -22.78% | $135 → $122 | Maintains | Buy | Get Alert |
| 08/05/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $16.22 | 54.13% | $26 → $25 | Maintains | Neutral | Get Alert |
| 08/04/2021 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 480.65% | $74 → $63 | Maintains | Buy | Get Alert |
| 07/21/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $16.22 | 60.3% | $24 → $26 | Maintains | Neutral | Get Alert |
| 06/16/2021 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 582.03% | $97 → $74 | Maintains | Buy | Get Alert |
| 02/26/2021 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -14.56% | $135 → $135 | Maintains | Buy | Get Alert |
| 02/12/2021 | PTCT | Buy Now | PTC Therapeutics | $30.00 | 126.67% | $58 → $68 | Downgrade | Buy → Neutral | Get Alert |
| 01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | -14.56% | → $135 | Maintains | Buy | Get Alert |
| 12/18/2020 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 22.78% | → $194 | Maintains | Buy | Get Alert |
| 12/01/2020 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 664.98% | $95 → $83 | Maintains | Buy | Get Alert |
| 11/16/2020 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 15.82% | → $183 | Maintains | Buy | Get Alert |
| 09/14/2020 | SAGE | Buy Now | Sage Therapeutics | $10.85 | 526.73% | $66 → $68 | Maintains | Buy | Get Alert |
| 06/10/2020 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 13.92% | $180 → $180 | Maintains | Buy | Get Alert |
| 03/27/2020 | SRPT | Buy Now | Sarepta Therapeutics | $158.00 | 13.92% | → $180 | Maintains | Buy | Get Alert |
| 11/02/2018 | DBVT | Buy Now | DBV Technologies | $0.80 | 3650% | $66 → $60 | Maintains | Buy | Get Alert |
